| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |